Andrew Siderowf

29.6k total citations · 3 hit papers
185 papers, 14.5k citations indexed

About

Andrew Siderowf is a scholar working on Neurology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Andrew Siderowf has authored 185 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Neurology, 55 papers in Psychiatry and Mental health and 43 papers in Physiology. Recurrent topics in Andrew Siderowf's work include Parkinson's Disease Mechanisms and Treatments (135 papers), Neurological disorders and treatments (63 papers) and Dementia and Cognitive Impairment Research (42 papers). Andrew Siderowf is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (135 papers), Neurological disorders and treatments (63 papers) and Dementia and Cognitive Impairment Research (42 papers). Andrew Siderowf collaborates with scholars based in United States, United Kingdom and Germany. Andrew Siderowf's co-authors include Daniel Weintraub, John E. Duda, Matthew B. Stern, Sharon X. Xie, Howard I. Hurtig, Marc N. Potenza, Anthony E. Lang, Bernard Ravina, Karl Kieburtz and Sarra Nazem and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Brain.

In The Last Decade

Andrew Siderowf

181 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

2006 1.8k citations Karl Kieburtz, Bernard Ravina et al. Neurology profile →
Impulse Control Disorders in Parkinson Disease

2010 971 citations Daniel Weintraub, Marc N. Potenza et al. profile →
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease

2009 929 citations Andrew Siderowf, John E. Duda et al. Neurology profile →

Peers

Countries citing papers authored by Andrew Siderowf

Since Specialization

Citations

This map shows the geographic impact of Andrew Siderowf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Siderowf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Siderowf more than expected).

Fields of papers citing papers by Andrew Siderowf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Siderowf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Siderowf. The network helps show where Andrew Siderowf may publish in the future.

Co-authorship network of co-authors of Andrew Siderowf

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Siderowf. A scholar is included among the top collaborators of Andrew Siderowf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Siderowf. Andrew Siderowf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Open‐Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated Dystonia 2025 ·Movement Disorders Clinical Practice ·Andres Deik, Whitley W. Aamodt, (unknown), A. G. Lasker, (unknown), Meredith Spindler, Thomas F. Tropea, Pavan A. Vaswani, Andrew Siderowf	2
2	Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older 2023 ·Neurology ·Michael C. Brumm, Kerri A. Pierz, David-Erick Lafontant, Chelsea Caspell‐Garcia, Christopher S. Coffey, Andrew Siderowf, Kenneth Marek	25
3	LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts 2023 ·npj Parkinson s Disease ·Kalpana Merchant, Tanya Simuni, (unknown), Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman, (unknown), F. Hsieh, Roy N. Alcalay, Christopher S. Coffey, Lana M. Chahine, Tatiana Foroud, Andrew Singleton, Daniel Weintraub, Samantha J. Hutten, Todd Sherer, Brit Mollenhauer, Andrew Siderowf, Caroline M. Tanner, Kenneth Marek, (unknown)	12
4	Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression 2023 ·Journal of Parkinson s Disease ·Michael C. Brumm, Andrew Siderowf, Tanya Simuni, (unknown), Seung Ho Choi, Chelsea Caspell‐Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, (unknown), Kathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey, (unknown)	25
5	Proposal for a Biologic Staging System of Parkinson’s Disease 2023 ·Journal of Parkinson s Disease ·Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, Todd Sherer, Caroline M. Tanner, Kenneth Marek, Tanya Simuni	45
6	Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors 2022 ·Sensors ·(unknown), (unknown), Barbara Marebwa, Tanya Simuni, (unknown), Andrew Siderowf, Mark Frasier, Magali Haas, Lee Lancashire	13
7	[18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease 2022 ·Cells ·Robert K. Doot, (unknown), Ilya M. Nasrallah, Reagan R. Wetherill, Andrew Siderowf, Robert H. Mach, Jacob G. Dubroff	7
8	Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies 2022 ·Journal of Neuropathology & Experimental Neurology ·David G. Coughlin, Annie Hiniker, Claire Peterson, (unknown), (unknown), Lucia Giannini, Donald Pizzo, Daniel Weintraub, Andrew Siderowf, Irene Litvan, Robert A. Rissman, Douglas Galasko, Lawrence A. Hansen, John Q. Trojanowski, Edward B. Lee, Murray Grossman, David J. Irwin	7
9	Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease 2020 ·Journal of Parkinson s Disease ·(unknown), Jacqueline Rick, Sharon X. Xie, Pablo Martínez‐Martín, Eugenia Mamikonyan, Alice Chen‐Plotkin, Nabila Dahodwala, James F. Morley, John E. Duda, John Q. Trojanowski, Andrew Siderowf, Daniel Weintraub	5
10	Impulse control disorders in parkinson disease: A multicenter case–control study 2011 ·Annals of Neurology ·Valerie Voon, Mandy Sohr, Anthony E. Lang, Marc N. Potenza, Andrew Siderowf, Jacqueline Whetteckey, Daniel Weintraub, Glen Wunderlich, Mark Stacy	284
11	CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease 2010 ·Neurology ·Andrew Siderowf, Sharon X. Xie, Howard I. Hurtig, Daniel Weintraub, John E. Duda, Alice Chen‐Plotkin, Leslie M. Shaw, Vivianna M. Van Deerlin, John Q. Trojanowski, C. Clark	281
12	Novel CSF biomarkers for frontotemporal lobar degenerations 2010 ·Neurology ·William T. Hu, Alice Chen‐Plotkin, Owen A. Ross, Steven E. Arnold, Christopher M. Clark, Les Shaw, Leo McCluskey, Igor Elman, Howard I. Hurtig, Andrew Siderowf, (unknown), Holly Soares, John Q. Trojanowski	74
13	Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study 2010 ·Annals of Neurology ·Daniel Weintraub, Mandy Sohr, Marc N. Potenza, Andrew Siderowf, Mark Stacy, Valerie Voon, Jacqueline Whetteckey, Glen Wunderlich, Anthony E. Lang	114
14	Long-Term Outcomes of Bilateral Subthalamic Nucleus Stimulation in Patients with Advanced Parkinson’s Disease 2006 ·Stereotactic and Functional Neurosurgery ·Grace Liang, Kelvin L. Chou, Gordon H. Baltuch, Jurg L. Jaggi, Catherine Loveland‐Jones, Lewis Z. Leng, (unknown), Howard I. Hurtig, Amy Colcher, Matthew B. Stern, Galit Kleiner‐Fisman, Tanya Simuni, Andrew Siderowf	69
15	Evidence from clinical trials: Can we do better? 2004 ·PubMed ·Andrew Siderowf	12
16	Evidence from clinical trials: Can we do better? 2004 ·Neurotherapeutics ·Andrew Siderowf	1
17	Diagnosis and treatment of Parkinson's disease: a systematic review of the literature. 2003 ·PubMed ·(unknown), Kyle Fahrbach, Andrew Siderowf, Rhonda Estok, (unknown), (unknown)	33
18	Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety 2002 ·Journal of neurosurgery ·Tanya Simuni, Jurg L. Jaggi, (unknown), Howard I. Hurtig, Amy Colcher, Andrew Siderowf, Bernard Ravina, Brett E. Skolnick, (unknown), Matthew B. Stern, Gordon H. Baltuch	121
19	MONOAMINE OXIDASE AND CATECHOL- O-METHYLTRANSFERASE INHIBITORS 1999 ·Medical Clinics of North America ·Andrew Siderowf, Roger Kurlan	8
20	Central neurogenic hyperventilation in an awake patient with a pontine glioma 1996 ·Neurology ·Andrew Siderowf, (unknown), Lawrence C. Kenyon, Maromi Nei, Eric C. Raps, S L Galetta	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact